secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tracon Pharmaceuticals, Inc. (—)
CIK:        0001394319
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0000950170-23-027292
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

TRACON receives Nasdaq deficiency notices for market value <$35M and bid price <$1.00
--------------------------------------------------------------------------------

- On June 8, 2023, TRACON received notices that its market value was below $35M and bid price below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until December 5, 2023, to regain compliance with both Nasdaq listing rules.
- To regain compliance, market value must be >= $35M and bid price >= $1.00 for ten consecutive business days during the grace period.
- If not compliant by deadline, could face delisting; company may appeal or seek additional 180-day period for bid price via reverse stock split.
- TRACON is evaluating potential actions to regain compliance; no assurance of maintaining listing on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394319/000095017023027292/0000950170-23-027292-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394319/000095017023027292/tcon-20230608.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-027292

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer